GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · IEX Real-Time Price · USD
31.83
-0.79 (-2.42%)
At close: Jul 19, 2024, 4:00 PM
31.85
+0.02 (0.06%)
Pre-market: Jul 22, 2024, 7:43 AM EDT
GeneDx Holdings Revenue
GeneDx Holdings had revenue of $221.85M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $62.42M with 44.70% year-over-year growth. In the year 2023, GeneDx Holdings had annual revenue of $202.57M.
Revenue (ttm)
$221.85M
Revenue Growth
-0.91%
P/S Ratio
3.75
Revenue / Employee
$221,849
Employees
1,000
Market Cap
832.38M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 202.57M | -32.13M | -13.69% |
Dec 31, 2022 | 234.69M | 22.50M | 10.60% |
Dec 31, 2021 | 212.20M | 32.87M | 18.33% |
Dec 31, 2020 | 179.32M | -16.85M | -8.59% |
Dec 31, 2019 | 196.17M | 62.83M | 47.12% |
Dec 31, 2018 | 133.34M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Healthcare Services Group | 1.68B |
InnovAge Holding | 741.33M |
Harrow Health | 138.68M |
CureVac | 64.13M |
AbCellera Biologics | 35.79M |
Liquidia | 15.97M |
Mesoblast | 7.25M |
Perspective Therapeutics | -304.00K |
WGS News
- 10 days ago - GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024 - GlobeNewsWire
- 5 weeks ago - GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients - GlobeNewsWire
- 6 weeks ago - GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients - GlobeNewsWire
- 2 months ago - GeneDx to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - GeneDx Reports First Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 3 months ago - GeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease Dataset - GlobeNewsWire
- 3 months ago - GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024 - GlobeNewsWire
- 4 months ago - GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics - GlobeNewsWire